NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood?

MeSH terms

• Cardiovascular Diseases / etiology
• Cardiovascular Diseases / prevention & control*
• Child
• Cholesterol / blood*
• Health Knowledge, Attitudes, Practice
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
• Hyperlipoproteinemia Type II / complications
• Hyperlipoproteinemia Type II / drug therapy
• Hyperlipoproteinemia Type II / epidemiology
• Mass Screening* / economics
• Mass Screening* / ethics
• National Heart, Lung, and Blood Institute (U.S.)
• Patient Education as Topic
• Practice Guidelines as Topic*
• Primary Prevention
• Risk
• United States